BioCircuit Technologies: Funding, Investors & Team (Sep 2026)
BioCircuit Technologies creates noninvasive electrophysiology devices that observe, manage, and heal peripheral nerves. These products empower clinicians to detect health conditions at an early stage, monitor symptom development, and choose personalized treatments with greater accuracy.
BioCircuit Technologies has raised $2.4M across 1 funding round on record, the most recent an undisclosed round of $2.4M announced in Oct 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioCircuit Technologies Company Profile and Key Stats
Latest funding round on record: Oct 2023.
BioCircuit Technologies Funding Rounds
BioCircuit Technologies Founders and Leadership Team
Contact details for the BioCircuit Technologies team: 1 of 1 has an email address on file.
Start 14-day free trial →BioCircuit Technologies Funding Compared to Other Biotechnology Startups
BioCircuit Technologies' latest round of $2.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioCircuit Technologies in Biotechnology and Atlanta
Companies Similar to BioCircuit Technologies
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
BioCircuit Technologies Funding FAQs
What does BioCircuit Technologies do?
BioCircuit Technologies creates noninvasive electrophysiology devices that observe, manage, and heal peripheral nerves. These products empower clinicians to detect health conditions at an early stage, monitor symptom development, and choose personalized treatments with greater accuracy.
How much funding has BioCircuit Technologies raised?
BioCircuit Technologies has raised $2.4M across 1 round on record. The most recent is an undisclosed round of $2.4M announced in Oct 2023.
When did BioCircuit Technologies last raise funding?
BioCircuit Technologies' most recent funding round on record is an undisclosed round of $2.4M, announced in Oct 2023.
Who founded BioCircuit Technologies?
FundedIQ lists Brandon Mark (Founder) at BioCircuit Technologies.
Where is BioCircuit Technologies headquartered?
BioCircuit Technologies is based in Atlanta, Georgia, United States.
How many employees does BioCircuit Technologies have?
BioCircuit Technologies is in the 11-50 employee band.
How does BioCircuit Technologies' funding compare to other Biotechnology startups?
BioCircuit Technologies' latest round of $2.4M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's BioCircuit Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioCircuit Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.